Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

2.

Year in Review: Multiple Myeloma

3.

Study finds 81% of cancer cures touted by TikTok videos are fake

4.

How artificial intelligence could significantly improve the prognosis for cancer patients.

5.

Sports for girls are frequently abandoned due to uniform issues.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot